A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesis

por Dearth, Robert K, Kuiatse, Isere, Wang, Yu-Fen, Liao, Lan, Hilsenbeck, Susan G, Brown, Powel H, Xu, Jianming, Lee, Adrian V
Publicado 2011

Inhibition of the MDM2 E3 Ligase Induces Apoptosis and Autophagy in Wild-Type and Mutant p53 Models of Multiple Myeloma, and Acts Synergistically with ABT-737

por Gu, Dongmin, Wang, Shuhong, Kuiatse, Isere, Wang, Hua, He, Jin, Dai, Yun, Jones, Richard J., Bjorklund, Chad C., Yang, Jing, Grant, Steven, Orlowski, Robert Z.
Publicado 2014

Intravenous Immunoglobulin G Suppresses Heat Shock Protein (HSP)-70 Expression and Enhances the Activity of HSP90 and Proteasome Inhibitors

por Jones, Richard J., Singh, Ram K., Shirazi, Fazal, Wan, Jie, Wang, Hua, Wang, Xiaobin, Ha, Min Jin, Baljevic, Muhamed, Kuiatse, Isere, Davis, Richard E., Orlowski, Robert Z.
Publicado 2020

Protein Targeting Chimeric Molecules Specific for Bromodomain and Extra-terminal Motif Family Proteins are Active Against Pre-Clinical Models of Multiple Myeloma

por Zhang, Xiaohui, Lee, Hans C., Shirazi, Fazal, Baladandayuthapani, Veerabhadran, Lin, Heather, Kuiatse, Isere, Wang, Hua, Jones, Richard J., Berkova, Zuzana, Singh, Ram Kumar, Lu, Jing, Qian, Yimin, Raina, Kanak, Coleman, Kevin G., Crews, Craig M., Li, Bingzong, Wang, Huihan, Hailemichael, Yared, Thomas, Sheeba K., Wang, Zhiqiang, Davis, R. Eric, Orlowski, Robert Z.
Publicado 2018

HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes

por Mbofung, Rina M., McKenzie, Jodi A., Malu, Shruti, Zhang, Min, Peng, Weiyi, Liu, Chengwen, Kuiatse, Isere, Tieu, Trang, Williams, Leila, Devi, Seram, Ashkin, Emily, Xu, Chunyu, Huang, Lu, Zhang, Minying, Talukder, Amjad H., Tripathi, Satyendra C., Khong, Hiep, Satani, Nikunj, Muller, Florian L., Roszik, Jason, Heffernan, Timothy, Allison, James P., Lizee, Gregory, Hanash, Sam M., Proia, David, Amaria, Rodabe, Davis, R. Eric, Hwu, Patrick
Publicado 2017

LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade

por Hickman, Amber, Koetsier, Joost, Kurtanich, Trevin, Nielsen, Michael C., Winn, Glenn, Wang, Yunfei, Bentebibel, Salah-Eddine, Shi, Leilei, Punt, Simone, Williams, Leila, Haymaker, Cara, Chesson, Charles B., Fa’ak, Faisal, Dominguez, Ana L., Jones, Richard, Kuiatse, Isere, Caivano, Amy R., Khounlo, Sayadeth, Warier, Navin D., Marathi, Upendra, Market, Robert V., Biediger, Ronald J., Craft, John W., Hwu, Patrick, Davies, Michael A., Woodside, Darren G., Vanderslice, Peter, Diab, Adi, Overwijk, Willem W., Hailemichael, Yared
Publicado 2022